Compare IDEXX Laboratories, Inc. (IDXX) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vital Farms Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Vital Farms Inc trades at $9.37 (market cap $405.27M). The key difference: IDEXX Laboratories, Inc. is far larger — about 99.8× Vital Farms Inc's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Vital Farms Inc for 14 Days on average.
| IDXX | VITL | |
|---|---|---|
Market Cap | $40.43B | $405.27M |
Volume | 692,164 | 1,810,837 |
Sector | Health | Consumer Staples |
52-Week High | $766.68 | $43.68 |
52-Week Low | $504.70 | $8.28 |
Typical Hold Time | 46 Days | 14 Days |
Enterprise Value | $41.32B | $492.28M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Vital Farms (VITL) trades at $9.36, up 1.3% on the day, amid a challenging period marked by recent earnings misses and a bearish technical signal. The stock shows weak profitability with a net margin of 0.02% in 2026, though valuation ratios like P/E of 11.77 and P/S of 0.55 appear modest. Recent news highlights strategic review speculation and institutional buying interest, providing some positive sentiment against operational headwinds.
The outlook remains cautious due to earnings volatility and cash flow concerns, but analyst consensus is bullish with a $13.11 price target. Key risks include egg pricing pressure and execution challenges, while potential upside hinges on strategic moves and demand recovery for pasture-raised eggs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
